SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-157922
Filing Date
2020-06-02
Accepted
2020-06-02 07:45:14
Documents
5
Period of Report
2020-05-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d830336d8k.htm 8-K 34178
2 EX-4.1 d830336dex41.htm EX-4.1 118755
3 EX-10.1 d830336dex101.htm EX-10.1 559318
4 EX-10.2 d830336dex102.htm EX-10.2 159053
5 EX-10.3 d830336dex103.htm EX-10.3 52464
  Complete submission text file 0001193125-20-157922.txt   925140
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 20935602
SIC: 8090 Services-Misc Health & Allied Services, NEC